Results in vitiligo came from the TRuE-V1 and TRuE-V2 studies, which showed that around 30% of patients treated with ruxolitinib cream twice daily achieved 75% or more improvement from baseline in ...

The Box2D library and samples build and run on Windows, Linux, and Mac. You will need a compiler that supports C17 to build the Box2D library. You will need a compiler that supports C++20 to build the ...